Thinly traded Twist Bioscience (TWST -4.2%) slips on 50% higher volume, a modest 340K shares, in apparent response to a report by The Friendly Bear who sees 50% downside ($13) from yesterday’s close citing potential penalties from an intellectual property theft lawsuit brought by Agilent (A -0.4%) who has a consistent track record of winning this type of case.
Agilent filed a whistleblower complaint with the SEC the day before Twist’s IPO.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.